XML 65 R50.htm IDEA: XBRL DOCUMENT
v3.24.0.1

LOSS PER SHARE (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Earnings Per Share [Abstract] |
Schedule of calculation of loss per share | Basic and diluted loss per share attributable to Bausch Health Companies Inc. for 2023, 2022 and 2021 was calculated as follows:
(in millions, except per share amounts) |  | 2023 |  | 2022 |  | 2021
Net loss attributable to Bausch Health Companies Inc. |  | $ | (592) |  |  | $ | (225) |  |  | $ | (948) |
Basic and diluted weighted-average common shares outstanding |  | 364.9 |  |  | 362.0 |  |  | 358.9 |
Basic and diluted loss per share attributable to Bausch Health Companies Inc. |  | $ | (1.62) |  |  | $ | (0.62) |  |  | $ | (2.64) |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration